Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease.
Nieminen, Tuomo
Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. [electronic resource] - Pharmacogenomics Oct 2008 - 1475-86 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8042
10.2217/14622416.9.10.1475 doi
Apolipoproteins E--genetics
Cholesterol, LDL--blood
Coronary Disease--genetics
Humans
Pharmacogenetics
Polymorphism, Genetic
Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. [electronic resource] - Pharmacogenomics Oct 2008 - 1475-86 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8042
10.2217/14622416.9.10.1475 doi
Apolipoproteins E--genetics
Cholesterol, LDL--blood
Coronary Disease--genetics
Humans
Pharmacogenetics
Polymorphism, Genetic